Rockwell Medical Q3 2026 net loss widens 33% year-over-year to $2.32 million

• Rockwell Medical’s third-quarter 2026 net loss widened 33% year over year to $2.32 million.
• Net sales rose 20% year over year to $19.12 million, driven by greater existing-customer purchases and new customers in the western United States.
• Gross profit climbed 37% year over year to $3.11 million, primarily driven by higher volumes.
• Following the quarter, Rockwell agreed to acquire Vantive’s global hemodialysis equipment, concentrates and related services business, including its Medolla, Italy, manufacturing campus.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rockwell Medical Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202611120600BIZWIRE_USPR_____20261112_BW177722) on November 12, 2026, and is solely responsible for the information contained therein.